(PO22-37-22) Effect of Folate and/or Vitamin B12 Supplementation Between 6 to 30 Months of Age on Markers of Cardiovascular Illness at School Age: A Secondary Analysis

The ePoster content is available to NUTRITION 2022 LIVE ONLINE attendees who are logged in.<br><br>If you are registered, log in and then come back here to use this button.

Presenting Author(s)

Rukman M. Manapurath, MD
– Research Scientist (Young Investigator), Centre for Health Research and Development, Society for Applied Studies, South Delhi, Delhi, India

Co-Author(s)

RC

Ranadip Chowdhury, MBBS, PhD
– Research Scientist, Centre for Health Research and Development, Society for Applied Studies, New Dehli, Delhi, India
ST

Sunita Taneja, MBBS, PhD
– Deputy Director and Senior Scientist, Centre for Health Research and Development, Society for Applied Studies, New Dehli, Delhi, India
NB

Nita Bhandari, MBBS, PhD, MNAMS
– Director and Senior Scientist, Centre for Health Research and Development, Society for Applied Studies, New Dehli, Delhi, India
TS

Tor A. Strand, PhD
– University of Bergen, Norway

Disclosure(s):

Rukman M. Manapurath, MD: No relevant financial relationship(s) with ineligible companies to disclose.

Objectives: Deficiencies of vitamin B12 and folate in childhood are associated with cardiovascular risk in later life. The main objective of this analysis is to measure the effect of vitamin B12 and/or folic acid supplementation in children between 6 to 30 months of age on biochemical markers of cardiovascular risk at school age.

Methods: This is a follow-up study of a randomized, 2X2 factorial, double-blind, placebo-controlled trial which assessed the effect of 2 recommended daily allowances of vitamin B12 and/or folic acid supplementation for 6 months on the risk of common infections in children aged between 6 to 30 months. The follow-up study was done 6 years later. The outcomes of the current analyses were plasma concentrations of total homocysteine, leptin, high molecular weight (HMW) adiponectin, and total adiponectin. We used multivariable linear regression to measure the effect of vitamin B12, folic acid, or both during early childhood on these outcomes. We included interaction terms in the statistical models to measure whether the two vitamins modified the effect of each other.

Results: Compared to the placebo, giving both B12 and folate supplementation resulted in 1.19 µmol/L (95% confidence interval: 0.09, 2.30) lower total homocysteine concentration at 7 years of age. There was no effect of B12 and folate supplementation on any of the other biomarkers. The effect of folic acid or vitamin B12 alone did not reach statistical significance for any of the outcomes.

Conclusions: Vitamin B12 and folic acid supplementation in early life resulted in lower plasma homocysteine at school age. Elevated homocysteine is a risk factor for many illnesses and our findings support improving the status of these vitamins in early life.

Funding Sources: The main study and follow-up study were funded by Thrasher Research Fund and Research Council of Norway.